Methylamine

Methylamine

SCHEMBL3364530

CN.Cc1cccc(C(F)(F)F)c1

nearest known ligand 0.56

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.56
MAPK1 P28482 1/20 0.56
NFE2L2 Q16236 1/20 0.52
MEN1 O00255 1/20 0.50
HTT P42858 1/20 0.50
RAB9A P51151 1/20 0.50
KMT2A Q03164 1/20 0.50
KCNK3 O14649 1/20 0.49
KCNK9 Q9NPC2 1/20 0.49
RAPGEF4 Q8WZA2 1/20 0.49
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
HTR2B P41595 1/20 0.48
ACHE P22303 2/20 0.48
TAAR1 Q96RJ0 1/20 0.47
IDO1 P14902 2/20 0.46
HTR3E A5X5Y0 1/20 0.46
HTR3B O95264 1/20 0.46
HTR3A P46098 1/20 0.46
HTR3D Q70Z44 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL148048 0.95 NFE2L2 (0.55) TSHRMAPK1NFE2L2MEN1HTT
Ammonia Solution, Strong SCHEMBL1869257 0.93 NFE2L2 (0.53) TSHRMAPK1NFE2L2MEN1HTT
Bromide SCHEMBL27462091 0.93 NFE2L2 (0.53) TSHRMAPK1NFE2L2MEN1HTT
Ethylamine SCHEMBL8079279 0.90 TAAR1 (0.52) TSHRMAPK1NFE2L2MEN1HTT
SCHEMBL2341190 0.87 HTT (0.51) TSHRMAPK1NFE2L2MEN1HTT
M-Xylene SCHEMBL21585133 0.86 TSHR (0.56) TSHRMAPK1NFE2L2MEN1HTT
Methylamine SCHEMBL27581718 0.85 TSHR (0.65) TSHRMAPK1NFE2L2RAPGEF4HTR2A
Acetone SCHEMBL27922108 0.85 MEN1 (0.58) NFE2L2MEN1HTTRAB9AKMT2A
SCHEMBL16551075 0.84 CDK1 (0.50) TSHRMAPK1NFE2L2MEN1HTT
SCHEMBL2662898 0.83 PTPN5 (0.62) TSHRMAPK1NFE2L2MEN1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100105722-A1 Substituted 4,5,6,7-tetrahydrothienopyridines as KCNQ2/3 Modulators GRUENENTHAL GMBH (DE) 2010-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105722-A1 Substituted 4,5,6,7-tetrahydrothienopyridines as KCNQ2/3 Modulators KCNQ1, KCNQ3, KCNQ2 TSHR 2929/4885MAPK1 1262/4885NFE2L2 996/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.